期刊文献+

抗磷脂抗体对妊娠的影响 被引量:6

The influence of antiphospholipid antibody with pregnancy
下载PDF
导出
摘要 自身免疫性疾病或免疫功能异常影响妊娠,在自身免疫疾病中,抗磷脂综合征(antiphospholipid syndrome APS)占了一定比例。本文就抗磷脂抗体的性质进行详细阐述。血栓形成是APS的主要病理基础和突出临床表现,随着研究深入,APA对早孕期滋养细胞的影响越来越受到重视,而APA导致不良妊娠结局的作用机制,目前仍有争论。本文还介绍了APS最新的治疗进展,为今后的APS发病机制研究及临床治疗带来更多的启示。 Autoimmune disease or abnormal immunological function influences pregnancy outcome. Antipbospbolipid syndrome which causes generally studies and researches plays an important role in the autoimmune disease. This article introduces the peculiarity of antiphospbolipid antibody. Thrombosis is the main pathogenesy and clinical manifestation of APS. With more and more researches , the attitude has changed to the influence of antipbospbolipid antibody with tropboblast. While virtually all agree that the adverse pregnancy outcomes are consistent and key features of APS, the mechanism (s) involved arodebated. This article recommend the newest progression of therapy in AlaS. Hopefully this brief review will ignite further discussion, questions, and investigation.
作者 李萍 朱付凡
出处 《中国优生与遗传杂志》 2007年第3期115-117,110,共4页 Chinese Journal of Birth Health & Heredity
关键词 抗磷脂抗体 抗磷脂综合征 血栓形成 滋养细胞 治疗 Antipbospbolipid antibody Antipbospbolipid syndrome Thrombosis Tropboblast Therapy
  • 相关文献

参考文献21

  • 1JD Oosting, RHWM Derksen, HT Entjes, et al. Lupus anticoagulant activity is frequently dependent on the presence of beta 2 - glycoprotein I, Thromb[ J ]. Haemost, 1992,67 : 499 - 502.
  • 2EM Bevers, M Galli, T Barbui, et al, Lupus anticoagulant IgG' s (LA) are not directed to phospholipids only,but to a complex of lipid - bound human prothrombin, Thromb[J]. Haemost, 1991,66:629 - 632.
  • 3JD Oosting, RHWM Derksen, IWG Bobbink, et al, Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S : an explanation for their pathogenic mechanism? [J]. Blood, 1993,81:2618-2625.
  • 4Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome : a systematic review of the literature [J]. Blood,2003 , 101 : 1827 - 1832.
  • 5杨程德,Pojen P,Chen.抗凝血相关因子抗体检测方法的建立及临床应用[J].诊断学理论与实践,2004,3(4):243-245. 被引量:1
  • 6Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphatidylserine antibodies in women with recurrent abortion[J]. Indian J Med Sci, 2005 Aug,59(8) :347 -352.
  • 7Uleova - Gallova Z, Krauz V, Novakova P, et al. Anti - phospholipid antibodies against phosphatidylinositol and phosphatidylserine are ore significant in reproductive failure than antibodies against cardio- lipin only[J]. Am J Reprod Immunol, 2005 Aug,54(2) :112 -7.
  • 8周红,谷俊侠,许文荣.APS IgG通过非Fc受体途径诱导血液单核细胞表达TF活性[J].中国免疫学杂志,2003,19(8):561-564. 被引量:13
  • 9Cucnik S, Cucnik S,Bozic B,Kveder T,et al. Avidity of anti- beta2- glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome[J]. Ann N Y Acad Sci,2005 Jan, 1051:141 -7.
  • 10Zammiti W,Mtiraoui N,Kallel C,et al. A case -control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2 - glycoprotein I and annexin V[J]. Reproduction,2006 Apr,131 (4) :817 -22.

二级参考文献18

  • 1[1]Harris EN, Baguley E, Asherson RA, et al. Clinical and serological feature of the antiphospholipid syndrome [J].Br J Rheumatol, 1987,26(1 ):19-23
  • 2[2]McNeil HP, Simpson RJ, Chesterman CN, et al. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) [J]. Proc Natl Acad Sci USA, 1990, 87(11): 4120-4124.
  • 3[3]Hwang K, Grossman JM, Chen PP, et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin[J]. J Immunol, 2001, 167(12), 7192 -7198.
  • 4[4]Hwang KK, Yang CD, Chen PP, et al. A thrombin-cross reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C[J]. Arthritis Rheum, 2003, 48(6), 1622-1630
  • 5[5]Yang CD, Hwang KK, Chen PP, et al. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin [J]. J Immunol, 2004,172(9), 5765-5773.
  • 6[6]Yang CD, Chen SL, Shen N, et al. Detection of anti-recombinant β2-glycoprotein 1 and anti-recombinant β2-glycoprotein 1 fifth domain antibodies in sera from patients with systemic lupus erythematosus [J]. Rheumal Int, 1998, 18(1), 5-10.
  • 7[7]Tan EM,Cohen AS,Fries JF, et al. the 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982, 25(11): 1271-1277.
  • 8Roubey R A S, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis[J]. Lancet, 1997;350:1491-1493.
  • 9Roubey R A S. Update on antiphospholipid antibodies[ J]. Current Opinion in Rheumatology,2000; 12:374-378.
  • 10Amengual O,Atsumi T, Khamashta M A et al .The role tithe tissue factor pathway in the hypercoagulable state in patients with the antipholipid syndrome[J] .Thromb Haemost, 1998;79:276-281.

共引文献12

同被引文献84

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部